Nothing Special   »   [go: up one dir, main page]

JPS5661311A - Thial amide or prolonged pharmaceutical preparation comprising its salt - Google Patents

Thial amide or prolonged pharmaceutical preparation comprising its salt

Info

Publication number
JPS5661311A
JPS5661311A JP13850679A JP13850679A JPS5661311A JP S5661311 A JPS5661311 A JP S5661311A JP 13850679 A JP13850679 A JP 13850679A JP 13850679 A JP13850679 A JP 13850679A JP S5661311 A JPS5661311 A JP S5661311A
Authority
JP
Japan
Prior art keywords
thial
amide
salt
prolongably
pharmaceutical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13850679A
Other languages
English (en)
Japanese (ja)
Inventor
Takehisa Hata
Kenichi Nishimura
Mitsuru Yasumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to JP13850679A priority Critical patent/JPS5661311A/ja
Priority to AU63253/80A priority patent/AU6325380A/en
Priority to ZA00806383A priority patent/ZA806383B/xx
Priority to NZ195299A priority patent/NZ195299A/xx
Priority to BE0/202538A priority patent/BE885806A/fr
Priority to GB8034222A priority patent/GB2061111A/en
Priority to DE19803040042 priority patent/DE3040042A1/de
Priority to IT25577/80A priority patent/IT1134039B/it
Priority to FR8022802A priority patent/FR2467596A1/fr
Priority to NL8005873A priority patent/NL8005873A/nl
Publication of JPS5661311A publication Critical patent/JPS5661311A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP13850679A 1979-10-25 1979-10-25 Thial amide or prolonged pharmaceutical preparation comprising its salt Pending JPS5661311A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP13850679A JPS5661311A (en) 1979-10-25 1979-10-25 Thial amide or prolonged pharmaceutical preparation comprising its salt
AU63253/80A AU6325380A (en) 1979-10-25 1980-10-14 Long acting composition of tiaramide
ZA00806383A ZA806383B (en) 1979-10-25 1980-10-16 Long acting pharmaceutical composition
NZ195299A NZ195299A (en) 1979-10-25 1980-10-20 Prolonged action tiaramide compositions
BE0/202538A BE885806A (fr) 1979-10-25 1980-10-21 Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action
GB8034222A GB2061111A (en) 1979-10-25 1980-10-23 Long acting pharmaceutical composition
DE19803040042 DE3040042A1 (de) 1979-10-25 1980-10-23 Pharmazeutische zubereitung des tiaramids oder seiner pharmazeutisch vertraeglichen salze
IT25577/80A IT1134039B (it) 1979-10-25 1980-10-24 Composizione farmaceutica ad azione prolungata
FR8022802A FR2467596A1 (fr) 1979-10-25 1980-10-24 Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action
NL8005873A NL8005873A (nl) 1979-10-25 1980-10-24 Farmaceutisch preparaat met langdurige werking.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13850679A JPS5661311A (en) 1979-10-25 1979-10-25 Thial amide or prolonged pharmaceutical preparation comprising its salt

Publications (1)

Publication Number Publication Date
JPS5661311A true JPS5661311A (en) 1981-05-26

Family

ID=15223717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13850679A Pending JPS5661311A (en) 1979-10-25 1979-10-25 Thial amide or prolonged pharmaceutical preparation comprising its salt

Country Status (10)

Country Link
JP (1) JPS5661311A (de)
AU (1) AU6325380A (de)
BE (1) BE885806A (de)
DE (1) DE3040042A1 (de)
FR (1) FR2467596A1 (de)
GB (1) GB2061111A (de)
IT (1) IT1134039B (de)
NL (1) NL8005873A (de)
NZ (1) NZ195299A (de)
ZA (1) ZA806383B (de)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58189109A (ja) * 1982-04-22 1983-11-04 Fujisawa Pharmaceut Co Ltd 医薬組成物
JPS61251617A (ja) * 1985-03-13 1986-11-08 レイクスニフエルシテイト　グロニンゲン １つ又はそれ以上の活性成分を液に調整放出する組成物及びその調整方法
JPS6354316A (ja) * 1986-07-23 1988-03-08 アルファ・ワッセルマン・エッセ・ピ・ア 消炎作用を示す計画的放出型経口投与用医薬製剤
JPH01279823A (ja) * 1988-01-18 1989-11-10 Alfa Wassermann Spa 放出性がプログラムされた製剤
USRE45198E1 (en) 1996-01-04 2014-10-14 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388041A (en) * 1964-01-27 1968-06-11 Richardson Merrell Inc High dosage sustained release tablet
JPS5495719A (en) * 1978-01-09 1979-07-28 Fujisawa Pharmaceut Co Ltd Pharmaceutical composition containing tiaramide of its acid addition salt, and its preparation

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58189109A (ja) * 1982-04-22 1983-11-04 Fujisawa Pharmaceut Co Ltd 医薬組成物
JPS61251617A (ja) * 1985-03-13 1986-11-08 レイクスニフエルシテイト　グロニンゲン １つ又はそれ以上の活性成分を液に調整放出する組成物及びその調整方法
JPS6354316A (ja) * 1986-07-23 1988-03-08 アルファ・ワッセルマン・エッセ・ピ・ア 消炎作用を示す計画的放出型経口投与用医薬製剤
JPH01279823A (ja) * 1988-01-18 1989-11-10 Alfa Wassermann Spa 放出性がプログラムされた製剤
USRE45198E1 (en) 1996-01-04 2014-10-14 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Also Published As

Publication number Publication date
BE885806A (fr) 1981-04-21
NZ195299A (en) 1983-06-14
DE3040042A1 (de) 1981-05-14
IT8025577A0 (it) 1980-10-24
AU6325380A (en) 1981-04-30
FR2467596A1 (fr) 1981-04-30
GB2061111A (en) 1981-05-13
NL8005873A (nl) 1981-04-28
IT1134039B (it) 1986-07-24
ZA806383B (en) 1981-10-28

Similar Documents

Publication Publication Date Title
IL71506A (en) Rapid dissolving,uniform pharmaceutical compositions of low water solubility drugs and their preparation
SE8402551L (sv) Cinnamoylmoranolin-derivat
KR890009376A (ko) 분무 건조된 이부프로펜
MY102459A (en) Oral sustained release pharmaceutical preparation.
ATE73656T1 (de) Entzuendungshemmendes ibuprofen enthaltendes arzneimittel, das in waessriger loesung keinen bitteren geschmack, keine reizung des kehlkopfes und keine intestinale toxizitaet aufweist.
DE2966564D1 (en) Therapeutic compositions with enhanced bioavailability and process for their preparation
BE901328A (fr) Composition pharmaceutique a absorption reglee.
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
JPS5661311A (en) Thial amide or prolonged pharmaceutical preparation comprising its salt
ES476106A1 (es) Procedimiento para la preparacion de 4-espectinomicilamina.
JPS56140924A (en) Calcitonin pharmaceutical preparation
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
IE791995L (en) Formulation
JPS5350316A (en) Drug composition for oral administration
JPS5441320A (en) Slow release preparation and its manufacturing
ZA784501B (en) Derivatives of n-substituted-2-aminobenzoic acid,processesfor their preparation and pharmaceutical compositions thereof
NO164958C (no) Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig, regulert frigjoering.
JPS5675423A (en) Physiologically active high polymer substance-containing composition for mucosa administration and its preparation
JPS57158719A (en) Rectal administration pharmaceutical
JPS57144214A (en) Pharmaceutical preparation for rectum medication
JPS5612309A (en) Oral drug containing ubidecarenone
SE8204792L (sv) N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metyl-propyl)-4-oxotieno(2,3-d)pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt
JPS53149939A (en) Novel benzyl alcohol derivatives and their preparation
RU2276982C2 (ru) Средство, обладающее противовоспалительным, анальгетическим, жаропонижающим действием в форме таблетки
JPS5441321A (en) Remedy for skin diseases and its preparation